Latest Leadership News

Imagion Biosystems has received encouraging feedback from the FDA on its MagSense HER2 breast cancer imaging program, clearing the path for a Phase 2 clinical trial and fast-tracking manufacturing.

Janison Education Group has been appointed by the New Zealand Ministry of Education to deliver a new bilingual digital assessment platform for students in Years 3 to 10, marking a strategic expansion into the New Zealand education sector.

CleanSpace Holdings reports a robust 26% increase in FY25 revenue, driven by strong growth across Europe, North America, and APAC regions, underscoring its expanding footprint in industrial respiratory protection.

Ava Risk Group reports a 5% revenue increase and a positive EBITDA turnaround in FY25, underpinned by its advanced security technologies. The company eyes over $88 million in FY26 sales opportunities despite some project delays.

oOh!media has confirmed that its contract with Auckland Transport, accounting for 4% of FY24 revenue, will not be renewed after September 2025. Despite this setback, the company remains confident in its New Zealand market position.

Ava Risk Group reports a positive EBITDA turnaround for FY2025 despite missing revenue guidance due to delayed key orders. The company highlights strong momentum in telecommunications and aviation sectors with promising technology deployments.

Redivium Limited has initiated a comprehensive business review and advisor appointment process aimed at exploring restructuring options to enhance long-term shareholder value and governance.

HUB24 Limited has reported a record $19.8 billion in net inflows for FY25, driven by strong platform growth and significant migrations from Equity Trustees. The company also launched an innovative high net worth solution, reinforcing its market leadership.

Larvotto Resources is exploring a USD 100 million senior secured bond to finance the restart of its Hillgrove Antimony and Gold Project, signaling a major step in advancing its mineral portfolio.

Advanced Health Intelligence has been formally delisted from NASDAQ due to shareholder equity deficiencies but is actively pursuing ASX reinstatement as a critical step toward regaining its dual-listing status.

INOVIQ Limited reports strong clinical validation for its EXO-OC ovarian cancer screening test and promising preclinical results for CAR-exosome therapeutics targeting aggressive cancers.

Uvre Limited has completed its acquisition of promising New Zealand gold assets and appointed seasoned mining executives to its board, setting the stage for an accelerated exploration phase.